Eli Lilly and Company · 1 day ago
Director/Sr Director/Executive Director - MSAT - Dry Products Network
Indianapolis, IN
Full-time
Onsite
Director/Executive
$141K/yr - $246K/yr
10+ years expEli Lilly and Company is a global healthcare leader headquartered in Indianapolis, Indiana, dedicated to making life better for people around the world. The Director/Sr. Director/Executive Director, MSAT - Dry Products Network is responsible for providing technical leadership for drug product manufacturing processes, ensuring the successful commercialization of new dry oral solid drug products and driving organizational improvements within the network.
BiotechnologyHealth CareMedicalPharmaceutical
Responsibilities
Serve as Manufacturing TS/MS representative to work with Product Development, CM&C teams, Manufacturing sites, and applicable functional areas to commercialize new dry oral solid drug products
Leverage prior experience to anticipate commercial manufacturing challenges for new dry products. Work across Development and Manufacturing site(s) to implement appropriate product control strategies based on anticipated needs
Serve as the Global Molecule Steward for select oral solid dosage form drug products. Collaboratively integrate different disciplines such as engineering and analytical science on technical projects, process performance improvements, or control strategy effectiveness. Provide proficient data analysis and conclusions considering technical, Regulatory and Quality compliance, and business needs
Achieve network level results for Lilly’s dry products (oral solid dosage forms) that improve effectiveness of TS/MS, Lilly Manufacturing, or other parts of the business by driving significant organizational improvement and capability work. Influence global leadership in driving improvements and resolving issues
Provide technical leadership for manufacturing process transfers between Lilly and external manufacturing sites as well as additional technical support/guidance for external manufacturing as needed. Drive appropriate shared learning, alignment and improvement across sites and network level activity according to best practices and technical principles
Ensure that experiments and technical work are well designed and appropriately rigorous. Use first principles and theoretical knowledge to define scientific approaches to support technical expectations. Utilize in depth understanding of materials, process, and product to improve product/process robustness, reduce variability, and provide improvement or advanced application of control strategies across sites and technologies
Collaborate with Project Managers on key product project plans and support timely delivery of milestones with appropriate risk mitigation strategies
Leverage prior experience and knowledge as a recognized Subject Matter Expert to collaborate with Development and manufacturing sites in the optimization of key manufacturing platforms such as continuous manufacturing. Influence Development on new product or platform topics in line with Manufacturing needs. Identify and lead the deployment of other new technology as appropriate
Author technical reports and appropriate sections of regulatory submission and responses as needed. Prepare technical aspects of other Regulatory/Quality based documents and support Regulatory reviews and inspections as needed
Remain current on external pharmaceutical manufacturing trends and innovations. Leverage these to improve strategies and applications for developing and controlling manufacturing processes
Prepare, review, and approve study designs, protocols, technical reports, and other related technical documentation. As a reviewer of technical reports, provide input on the experimental findings and conclusions
Mentor and provide review/coaching to develop other technical resources on scientific approach, technology, as well as business approach and behaviors
Qualification
Required
Bachelor's or Masters in Chemistry, Engineering, Pharmacy, or related science with minimum 15 years of direct experience in Dry products Manufacturing and Development/Commercialization
PhD in Chemistry, Engineering, Pharmacy, or related science with minimum 10 years of direct experience in Dry products Manufacturing and Development/Commercialization is preferred
Technical expertise in multiple areas, unit operations, and platforms related to technical support of dry products (oral solid dosage forms) commercial manufacturing as well as experience in development and commercialization of these dosage forms
Preferred
Flexibility to interact with multiple partners/functions, regions, and cultures
Demonstrated, strong technical leadership and communication skills. Communicates effectively across disciplines and types of audiences (internal and external) to influence and/or drive common understanding and appropriate actions
Ability to work well independently, as well as in teams. Provides partnership and collaboration across multiple disciplines. Ability to lead teams effectively
Demonstrated, strong analytical and problem-solving abilities
Effective at integrating multiple technology disciplines to drive programs forward
Benefits
Company-sponsored 401(k)
Pension
Vacation benefits
Eligibility for medical, dental, vision and prescription drug benefits
Flexible benefits (e.g., healthcare and/or dependent day care flexible spending accounts)
Life insurance and death benefits
Certain time off and leave of absence benefits
Well-being benefits (e.g., employee assistance program, fitness benefits, and employee clubs and activities)
Company
Eli Lilly and Company
We're a medicine company turning science into healing to make life better for people around the world.
10001+ employees
H1B Sponsorship
Eli Lilly and Company has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (514)
2024 (236)
2023 (167)
2022 (133)
2021 (57)
2020 (52)
Funding
Current Stage
Public CompanyTotal Funding
$6.5M2024-02-12Post Ipo Debt· $6.5M
1978-01-13IPO
Leadership Team
David Ricks
Chair, CEO
Lucas Montarce
Executive Vice President and Chief Financial Officer
Recent News
Company data provided by crunchbase